Luo et al. showed that ZC3H13 might bind with K‐Ras, which is frequently mutated in various cancers, such as non‐small cell lung cancer (NSCLC) and colon carcinoma 31, 32, and is tightly associated with cancer progression. Here, ZC3H13 is linked to non-small cell lung carcinoma.